Introduction
Menorrhagia and easy bruising are stated to be commonly occurring presenting symptoms in hypothyroidism."2 Anaemia is found not infrequently in patients with hypothyroidism: in a review of 202 cases, 23% of female patients and 47% of male patients were found to be anaemic at presentation.3 Despite this, significant blood loss in patients with untreated hypothyroidism has been reported only rarely.4'5 A possible link between the two could be a haemostatic defect similar to that of von Willebrand's disease which would be present in the untreated state and which would resolve on effective therapy of the hypothyroidism, i.e. acquired von Willebrand's disease.6
Case report
The patient was a 17 year old female who had been well until 10 days previously when she started to menstruate. After 3 days, the blood flow increased and she started to complain of tiredness. She consulted her general practitioner who requested a full blood count which was reported as showing pancytopenia with atypical cells, possibly blasts, seen on the peripheral blood film.
She was referred to the Haematology Department of Glasgow Royal Infirmary for further investigation. On admission, she complained of tiredness and continued to have vaginal blood loss. Although her menstrual cycle was irregular, she had not had menorrhagia in the past. She denied any history of easy bruising, of epistaxis or of excessive blood loss following surgical or dental procedures. There was no family history of a bleeding disorder nor of any thyroid disorder. Apart from oral ferrous sulphate which had been started by her general practitioner at the initial consultation, she was not taking any other medication.
On examination, she was anaemic. Height was 145 cm and weight was 61 kg. There was no lymphadenopathy nor splenomegaly. Examination of the cardio-respiratory and gastrointestinal system was normal. Apart from some puffiness of her face, there were no other features suggestive of a thyroid disorder. Gynaecological examination was normal.
Investigation of peripheral blood revealed haemoglobin concentration of 52 g/l, total leucocyte count of 8.5 x 109/l and platelet count of 263 x 109/l. Reticulocyte count was elevated at 9% and mean red cell volume (MCV) was elevated at 100 fl (the normal range for this laboratory, 76-96 fl). Peripheral blood film showed polychromasia of erythrocytes with an occasional nucleated red cell being seen; leucocytes were normal in type and distribution and, in particular, no blast cells were seen. Bone marrow aspiration yielded only blood. However, trephine biopsy showed a marrow of slightly decreased cellularity but with normal maturation of all cellular elements. Results of investigation of haemostatic system are shown in Table I .
Renal and liver function tests were normal. Thyroid function tests were as follows: serum thyroxine (T4) 26 nmol/I (normal range 55-144 nmol/l), serum tri-iodothyronine (T3) 0.8 nmol/l (normal range 0.9-2.8 nmol/l) and serum thyroid stimulating hormone (TSH) 272 mU/l (normal range < 5 mU/l). Thyroid microsomal antibody and thyroglobulin antibody were negative.
Initial therapy included blood transfusion to correct anaemia and oral thyroxine, initially 50 1sg daily and gradually increasing to 200 ltg daily to correct hypothyroidism. On this therapy, she became euthyroid and menstruation became regular with no recurrence of menorrhagia. Haemostatic function (Table I ) has returned to normal and the haemoglobin has remained stable without any blood transfusions or haemotinic therapy.
Materials and methods
Full blood count was performed using Coulter S Plus (Coulter Electronics Ltd, Bedford). Coagulation studies were performed manually using standard methods.7 Factor VIII:C was measured by a One-stage technique.8 Von Willebrand factor antigen (vWF: Ag) was assayed by a Laurell technique9 and Ristocetin Co-factor (RiCoF) was measured by a platelet aggregation method.'0 Analysis of multimers of von Willebrand factor (vWF) was performed by SDS polyacrylamide gel electrophoresis. " l 2 Bleeding time was measured by a template method (Simplate, General Diagnostics, New Jersey, USA).
Discussion
The patient described above showed defects in her haemostatic system consistent with the diagnosis of von Willebrand's disease, type IA. The main clinical effect ofthis was menorrhagia which caused severe anaemia requiring blood transfusion. The patient was found to be severely hypothyroid and on correction of the hypothyroid state, the haemostatic defects returned to normal suggesting that the lack ofthyroid hormones played a fundamental role in the decreased levels of factor VIII which on multimeric analysis was normal, i.e. there was a quantitative rather than a qualitative defect of factor VIII production.
Acquired von Willebrand's disease has been associated usually with a circulating IgG antibody which acts as a functional inhibitor of the factor VIII molecule and which has been associated with various underlying disorders such as systemic lupus erythematosus,'3"14 non-Hodgkin's lymphoma '5 and myeloma.'6 However, recent reports have indicated that hypothyroidism may cause a decrease in the circulating factor VIII level without the presence of an inhibitor.6"7 The precise mechanism is not known; at a cellular level triiodothyronine acts on nuclear receptors to cause an increase in m-RNA sequences'8 and it is tempting to speculate that, in the presence of reduced levels of thyroid hormone, decreased amounts of m-RNA specific for factor VIII components would lead to a decrease of the synthesis of the factor VIII molecule. The possibility of acquired von Willebrand's disease and hypothyroidism should be kept in mind in patients presenting with menorrhagia. Unexplained bleeding or easy bruising in patients presenting with hypothyroidism should prompt full investigation of the haemostatic system.
